IL173552A0 - T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds - Google Patents

T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds

Info

Publication number
IL173552A0
IL173552A0 IL173552A IL17355206A IL173552A0 IL 173552 A0 IL173552 A0 IL 173552A0 IL 173552 A IL173552 A IL 173552A IL 17355206 A IL17355206 A IL 17355206A IL 173552 A0 IL173552 A0 IL 173552A0
Authority
IL
Israel
Prior art keywords
receptors
taste
hetero
express
cell lines
Prior art date
Application number
IL173552A
Other versions
IL173552A (en
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of IL173552A0 publication Critical patent/IL173552A0/en
Publication of IL173552A publication Critical patent/IL173552A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/56—Flavouring or bittering agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/202—Aliphatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/203—Alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/205—Heterocyclic compounds
    • A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/88—Taste or flavour enhancing agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Seasonings (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL173552A 2003-08-06 2006-02-06 T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds IL173552A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49407103P 2003-08-06 2003-08-06
US55206404P 2004-03-09 2004-03-09
PCT/US2004/025459 WO2005015158A2 (en) 2003-08-06 2004-08-06 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds

Publications (2)

Publication Number Publication Date
IL173552A0 true IL173552A0 (en) 2006-07-05
IL173552A IL173552A (en) 2012-10-31

Family

ID=34138798

Family Applications (3)

Application Number Title Priority Date Filing Date
IL173551A IL173551A (en) 2003-08-06 2006-02-06 Rich compounds and history and methods for regulating the taste of products by using them
IL173552A IL173552A (en) 2003-08-06 2006-02-06 T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds
IL207954A IL207954A0 (en) 2003-08-06 2010-09-02 T1r hetero-oligomeric taste receptors, binding compounds and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL173551A IL173551A (en) 2003-08-06 2006-02-06 Rich compounds and history and methods for regulating the taste of products by using them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL207954A IL207954A0 (en) 2003-08-06 2010-09-02 T1r hetero-oligomeric taste receptors, binding compounds and uses thereof

Country Status (19)

Country Link
US (15) US7476399B2 (en)
EP (3) EP1659881B1 (en)
JP (4) JP5036310B2 (en)
CN (1) CN103275058B (en)
AR (1) AR046078A1 (en)
AU (3) AU2004285410B2 (en)
BR (2) BRPI0413347A (en)
CA (3) CA2535045A1 (en)
CL (2) CL2004002015A1 (en)
ES (1) ES2733577T3 (en)
IL (3) IL173551A (en)
MX (1) MXPA06001510A (en)
MY (1) MY174572A (en)
NZ (6) NZ597500A (en)
PH (8) PH12015501665A1 (en)
RU (3) RU2006106920A (en)
SG (2) SG153714A1 (en)
WO (2) WO2005041684A2 (en)
ZA (1) ZA200601904B (en)

Families Citing this family (256)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7763431B1 (en) 2001-03-07 2010-07-27 Senomyx, Inc. Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste
US7301009B2 (en) 2001-06-26 2007-11-27 Senomyx, Inc. Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
US20080244761A1 (en) 2001-03-07 2008-10-02 Senomyx, Inc. T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
US7368285B2 (en) 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US7309577B2 (en) 2001-03-07 2007-12-18 Senomyx, Inc. Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
US7794959B2 (en) * 2001-04-05 2010-09-14 Senomyx, Inc. Identification of bitter receptors for hydrolyzed soy protein
US10078087B2 (en) * 2001-05-01 2018-09-18 Senomyx, Inc. Assays and enhancers of the human delta ENaC sodium channel
DK2327985T3 (en) * 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
EP1483283A4 (en) 2002-03-13 2007-04-11 Signum Biosciences Inc MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
MXPA06000266A (en) 2003-07-10 2006-03-30 Senomyx Inc IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES.
US7906627B2 (en) 2003-08-06 2011-03-15 Senomyx, Inc. Chimeric human sweet-umami and umami-sweet taste receptors
CN103275058B (en) 2003-08-06 2016-02-24 西诺米克斯公司 Seasonings, taste modulators, tastant, taste enhancer, tasty agents or sweeting agent and/or toughener and uses thereof
ES2342466T7 (en) 2003-11-21 2012-11-19 Givaudan Sa P-MENTANOCARBOXAMIDS N-SUBSTITUTED.
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US7541055B2 (en) * 2004-09-10 2009-06-02 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
US7427421B2 (en) * 2004-09-10 2008-09-23 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
GB0425661D0 (en) * 2004-11-23 2004-12-22 Givaudan Sa Organic compounds
WO2006068745A1 (en) 2004-12-22 2006-06-29 Cargill, Incorporated Methods for determining cellular response to stimuli
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
KR101340859B1 (en) * 2005-02-04 2013-12-13 세노믹스, 인코포레이티드 Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
US20060257543A1 (en) * 2005-02-04 2006-11-16 Catherine Tachdjian Molecules comprising linked organic moieties as flavor modifiers for comestible compositions
EP1860960A1 (en) * 2005-03-24 2007-12-05 Givaudan SA Cooling compounds
US7560465B2 (en) * 2005-03-31 2009-07-14 Richard Holschen Compositions and methods for delivery of caffeine
CA2604760C (en) * 2005-05-23 2012-06-26 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
US7851005B2 (en) 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
US7851006B2 (en) 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
EP2368442B1 (en) 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
CN101605810B (en) * 2005-10-20 2013-07-17 塞诺米克斯公司 Chimeric human sweet-umami and umami-sweet taste receptors
KR101219281B1 (en) * 2005-10-31 2013-01-08 (주)아모레퍼시픽 Gentisic acid derivatives and preparation method thereof and whitening cosmetic composition containing it
KR20080069233A (en) * 2005-11-04 2008-07-25 아지노모토 가부시키가이샤 Gastrointestinal function promoter
EP2299271B9 (en) * 2005-11-09 2014-02-26 Ajinomoto Co., Inc. Kokumi-imparting compositions
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
HRP20161260T1 (en) * 2005-11-24 2016-11-18 Dompé Farmaceutici S.P.A. (R) -ARYLKYLAMINE DERIVATIVES AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM
US8007849B2 (en) * 2005-12-14 2011-08-30 International Flavors & Fragrances Inc. Unsaturated cyclic and acyclic carbamates exhibiting taste and flavor enhancement effect in flavor compositions
EP2047254B1 (en) * 2006-04-20 2015-10-28 Givaudan SA Method relating to sweetness enhancement
WO2007121599A1 (en) 2006-04-20 2007-11-01 Givaudan Sa Functional method to identify tastants
CN101426381A (en) * 2006-04-21 2009-05-06 西诺米克斯公司 Edible composition containing high-potency savory flavoring and method of making same
EP3235811B1 (en) * 2006-04-21 2018-07-25 Senomyx, Inc. Process of preparing oxalamides
EP2035827B1 (en) * 2006-06-19 2012-10-17 Givaudan S.A. Nucleic acid, polypeptide and its use
WO2008013969A2 (en) * 2006-07-28 2008-01-31 Senomyx, Inc. IMPROVED CELL-BASED FLUORESCENT ASSAYS FOR IDENTIFYING ALPHA AND DELTA ENaC MODULATORS
WO2008024364A2 (en) * 2006-08-22 2008-02-28 Redpoint Bio Corporation Heterocyclic compounds as sweetener enhancers
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
KR101511394B1 (en) * 2007-01-18 2015-04-10 지보당 에스아 Chimeric umami taste receptor, nucleic acid encoding it and use thereof
US20080220140A1 (en) 2007-01-25 2008-09-11 Symrise Gmbh & Co. Kg Use of propenylphenyl glycosides for enhancing sweet sensory impressions
EP1977655B1 (en) 2007-03-29 2011-05-18 Symrise AG Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions
US8765207B2 (en) * 2007-04-10 2014-07-01 Paul Coles Fruit product containing sugar alcohol
DE502008000732D1 (en) * 2007-05-08 2010-07-15 Symrise Gmbh & Co Kg Substituted cyclopropanecarboxylic acid (3-methylcyclohexyl) amides as flavoring agents
WO2008143963A1 (en) * 2007-05-17 2008-11-27 Cortex Pharmaceuticals, Inc. Di-substituted amides for enhancing glutamatergic synaptic responses
US8709521B2 (en) * 2007-05-22 2014-04-29 The Coca-Cola Company Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles
US7928111B2 (en) * 2007-06-08 2011-04-19 Senomyx, Inc. Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
US20080305500A1 (en) * 2007-06-08 2008-12-11 Senomyx, Inc. Novel cell-based assays for identifying enhancers or inhibitors of t1r taste receptors (t1r2/t1r3 sweet) and umami (t1r1/t1r3 umami) taste receptors
US8633186B2 (en) 2007-06-08 2014-01-21 Senomyx Inc. Modulation of chemosensory receptors and ligands associated therewith
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
AU2013202912B2 (en) * 2007-06-08 2016-10-27 Firmenich Incorporated Modulation of chemosensory receptors and ligands associated therewith
EP2179651A4 (en) * 2007-06-29 2012-07-11 Sumitomo Chemical Co AGENT FOR CONTROLLING PLANT DISEASES AND METHOD THEREOF
EP2064959B1 (en) 2007-10-31 2012-07-25 Symrise AG Aromatic Neomenthylamides as flavouring agents
WO2009102569A2 (en) * 2008-02-01 2009-08-20 Chromocell Corporation Novel cell lines and methods
TWI429404B (en) 2008-03-03 2014-03-11 Senomyx Inc Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
AU2009239430B2 (en) 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
EP2135516B1 (en) * 2008-06-13 2012-08-15 Symrise AG Neo-menthyl derivatives as flavourings
UA117296C2 (en) 2008-07-31 2018-07-10 Сіномікс, Інк. METHODS AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF SWEET AMPLIFIERS
DK2328426T3 (en) 2008-07-31 2014-12-08 Senomyx Inc COMPOSITIONS INCLUDING SWEET AMPLIFIERS AND PROCEDURES FOR PRODUCING THEREOF
DE102008042421A1 (en) 2008-09-26 2010-04-01 Symrise Gmbh & Co. Kg Geranylamine derivatives of oxalic acid
SG172321A1 (en) * 2009-01-29 2011-07-28 Commw Scient Ind Res Org Measuring g protein coupled receptor activation
PL216572B1 (en) * 2009-02-02 2014-04-30 Inst Chemii Organicznej Polska Akademia Nauk Enaminocarbonylic compounds and their application
RU2377823C1 (en) * 2009-02-13 2010-01-10 Олег Иванович Квасенков Production method of aromatised girasol-sunflower-peach drink
RU2377829C1 (en) * 2009-02-27 2010-01-10 Олег Иванович Квасенков Production method of aromatised coffee drink "stoupinsky"
DE102009002268A1 (en) 2009-04-07 2010-10-14 Leibniz-Institut Für Pflanzenbiochemie Use of 4,4'-dihydroxydeoxybenzoin compound for masking or reducing unpleasant taste of an unpleasant tasting material, and/or strengthening the sweet tasting material of sweet material
US20100292175A1 (en) 2009-05-15 2010-11-18 Leibniz-Institut fur Pflanzenbiochemie Use of hydroxyflavan derivatives for taste modification
CN102469816A (en) * 2009-08-10 2012-05-23 斯托克里-丰康普公司 Method for suspending flavonoids in beverages
US10624372B2 (en) 2009-08-28 2020-04-21 Symrise Ag Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type
EP2298084B1 (en) 2009-08-28 2011-10-19 Symrise AG Sweetener-reduced products, aromatic mixtures for same and method of producing such products
US8293299B2 (en) 2009-09-11 2012-10-23 Kraft Foods Global Brands Llc Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids
US20120245213A1 (en) * 2009-10-01 2012-09-27 Bedrich Mosinger Human type i taste receptor subunit 3 modulators and methods of using same
GB0917325D0 (en) 2009-10-02 2009-11-18 Givaudan Sa Flavour enhancement
DE102009046126A1 (en) 2009-10-28 2011-05-12 Symrise Ag Orally consumable preparation, useful e.g. in cosmetic preparation e.g. lipstick and as baked goods, comprises naturally occurring sweet-tasting substances and a root extract of Mondia whitei containing 2-hydroxy-4-methoxybenzaldehyde
JP5905187B2 (en) 2009-12-02 2016-04-20 国立大学法人 東京大学 Sweet receptor expression construct, cell body expressing the same, and use thereof
JP2011116693A (en) * 2009-12-02 2011-06-16 Univ Of Tokyo Sweet taste-regulating substance acting on human sweet taste receptor for sweet taste substance
CN102858192A (en) * 2009-12-18 2013-01-02 斯托克里-丰康普公司 Protein recovery beverage
EP2353403B1 (en) 2010-02-01 2012-07-11 Symrise AG Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on
GB201001796D0 (en) 2010-02-04 2010-03-24 Givaudan Sa Compounds
NZ603332A (en) * 2010-04-02 2014-11-28 Senomyx Inc Sweet flavor modifier
WO2011130707A2 (en) * 2010-04-15 2011-10-20 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
CN106107406B (en) * 2010-08-12 2020-06-09 弗门尼舍公司 Methods of improving the stability of sweetness enhancers and compositions comprising stable sweetness enhancers
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
WO2012054528A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2012054526A2 (en) * 2010-10-19 2012-04-26 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
JP2014505011A (en) * 2010-10-19 2014-02-27 エルセリクス セラピューティクス インコーポレイテッド Chemosensory receptor ligand based therapy
PE20140913A1 (en) 2010-11-15 2014-08-22 Abbvie Inc NAMPT AND ROCK INHIBITORS
CN103260434B (en) * 2010-11-30 2016-08-10 荷兰联合利华有限公司 Refined plant separator and thus plant separator produce the method for functional food ingredients
GB201103103D0 (en) 2011-02-23 2011-04-06 Givaudan Sa Organic compounds
CN103635096B (en) 2011-04-29 2016-08-17 洲际大品牌有限责任公司 Encapsulated acid, method for its preparation and chewing gum comprising said encapsulated acid
EP2529632B1 (en) 2011-05-31 2013-08-28 Symrise AG Cinnamic acid amides as spicy flavour agents
EP2529633B1 (en) 2011-06-01 2014-08-06 Symrise AG Orally consumed preparations comprising particular sweet tasting triterpenes and triterpene glycosides
CN102311352B (en) * 2011-07-11 2013-10-16 上海应用技术学院 Synthesis method for 2-methoxy-4-methylbenzylamine
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
MX336378B (en) * 2011-08-12 2016-01-15 Senomyx Inc Sweet flavor modifier.
EP2570036B1 (en) 2011-09-15 2014-06-18 Symrise AG Use of particular neoflavanoids for reinforcing and/or generating a sweet sensory sensation
GB201118481D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118480D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118486D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118479D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB201118497D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
WO2013135511A1 (en) 2012-03-12 2013-09-19 Imax Discovery Gmbh N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents
WO2013143822A1 (en) 2012-03-26 2013-10-03 Imax Discovery Gmbh Adenosine as sweetness enhancer for certain sugars
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
EP3593648B1 (en) 2012-08-06 2021-07-14 Firmenich Incorporated Sweet flavor modifier
EP2737807B1 (en) 2012-11-30 2017-04-05 Symrise AG Use of nitrogen-containing derivatives of cinnamic acid as flavourants
EP2742983B1 (en) 2012-12-11 2017-08-23 Symrise AG Method for isolating fragrance and flavour compounds
WO2014095564A1 (en) * 2012-12-21 2014-06-26 Firmenich Sa Taste-modifying combinations
JO3155B1 (en) 2013-02-19 2017-09-20 Senomyx Inc Sweet flavor modifier
US9804157B1 (en) 2013-03-15 2017-10-31 Senomyx, Inc. Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives
US9169311B2 (en) 2013-03-15 2015-10-27 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
US9603379B2 (en) 2013-03-15 2017-03-28 Applied Food Biotechnology, Inc Feline bitter taste receptors and methods
US10178875B2 (en) 2013-07-01 2019-01-15 Givaudan S.A. Methods of modifying or imparting taste using organic compounds
EP2832233A1 (en) * 2013-07-30 2015-02-04 IMAX Discovery GmbH 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents
EP2832234A1 (en) 2013-07-30 2015-02-04 IMAX Discovery GmbH Imidazo[1,2-a]pyridine-ylmethyl-derivatives and their use as flavoring agents
CN105683196B (en) 2013-09-11 2018-12-21 百时美施贵宝公司 Aryl ether-based kinase inhibitors
WO2015074064A2 (en) 2013-11-18 2015-05-21 Bair Kenneth W Tetrahydroquinoline compositions as bet bromodomain inhibitors
US9422281B2 (en) 2013-11-18 2016-08-23 Forma Therapeutics, Inc. Benzopiperazine compositions as BET bromodomain inhibitors
BR112016011747B1 (en) 2013-12-05 2020-11-24 Givaudan Sa USE OF A FLAVOR MODIFYING COMPOUND, EDIBLE COMPOSITION CONTAINING THE FIRST COMPOUND AS WELL AS A METHOD TO CONFER, INTENSIFY OR MODIFY A UMAMI AND / OR SALTED FLAVOR IN AN EDIBLE PRODUCT
EP2883459B1 (en) 2013-12-16 2018-04-04 Symrise AG Compositions for oral consumption
EP2918270A1 (en) 2014-03-12 2015-09-16 Symrise AG Derivatives of aromatic alkenoic acids for curbing appetite and enhancing mood
WO2015147552A1 (en) * 2014-03-26 2015-10-01 주식회사 엘지화학 Method for manufacturing polarizing members comprising locally bleached region, method for manufacturing polarizing member rolls, and method for manufacturing single-type polarizing members
JP6755640B2 (en) 2014-03-28 2020-09-16 味の素株式会社 Sweet receptor chimeric protein and its utilization
CN106455642B (en) * 2014-05-09 2021-03-02 弗门尼舍有限公司 Solubilization of sweetness modifiers and flavorings
AU2015343463A1 (en) 2014-11-07 2017-06-15 Senomyx, Inc. Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers
EP4403042A3 (en) 2014-12-10 2025-03-05 Mars, Incorporated Flavor compositions and pet food products containing the same
CN115418269A (en) * 2015-01-23 2022-12-02 P2科学公司 Fragrance and perfume compositions comprising neopentyl glycol diacetate
US10392371B2 (en) 2015-10-01 2019-08-27 Senomyx, Inc. Compounds useful as modulators of TRPM8
NZ741741A (en) 2015-10-29 2019-08-30 Senomyx Inc High intensity sweeteners
US11793222B2 (en) 2016-02-03 2023-10-24 Firmenich Sa Solutions and dispersions of amide compounds
LT3319949T (en) 2016-09-21 2020-11-10 Celanese International Corporation Acesulfame potassium compositions and processes for producing same
WO2018057387A1 (en) 2016-09-21 2018-03-29 Celanese International Corporation Acesulfame potassium compositions and processes for producing same
HRP20201619T4 (en) 2016-09-21 2025-03-28 Celanese International Corporation POTASSIUM ACESULFAME PREPARATIONS AND PROCESSES FOR ITS PRODUCTION
JP6818896B2 (en) 2016-09-21 2021-01-27 セラニーズ・インターナショナル・コーポレーション Acesulfame potassium composition and its production method
CN106620144B (en) * 2016-12-29 2020-01-24 姜富春 Traditional Chinese medicine preparation for treating chronic pelvic inflammatory disease and preparation method thereof
BR112019023104A2 (en) 2017-05-03 2020-11-03 Firmenich Incorporated methods for making high intensity sweetener
WO2019055464A1 (en) * 2017-09-12 2019-03-21 Monell Chemical Senses Center Compositions and methods for regulation of immune cell activation and proliferation
US11185074B2 (en) * 2017-09-13 2021-11-30 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
JP7173980B2 (en) 2017-10-23 2022-11-17 日本たばこ産業株式会社 Constructs for expressing G protein-coupled receptors or subunits thereof and uses thereof
EP3823455B1 (en) 2018-07-16 2025-10-01 Symrise AG Composition for substituting sugar in baked goods
US11945813B2 (en) 2018-08-07 2024-04-02 Firmenich Incorporated 5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
EP3806661B1 (en) 2018-08-10 2025-07-02 Firmenich Incorporated Use of antagonists of t2r54
CA3108469A1 (en) 2018-09-10 2020-03-19 Heineken Supply Chain B.V. Low-alcohol beer with reduced wort flavor
WO2020096905A1 (en) 2018-11-07 2020-05-14 Firmenich Incorporated Methods for making high intensity sweeteners
CN113286523A (en) 2018-11-07 2021-08-20 弗门尼舍公司 Process for preparing high intensity sweeteners
EP3911172A1 (en) 2019-01-18 2021-11-24 Symrise AG Combination remedy
EP3704954A1 (en) 2019-03-05 2020-09-09 Symrise AG Mixture comprising d-allulose and taste modifying compounds
WO2020193321A1 (en) 2019-03-28 2020-10-01 Firmenich Sa Flavor system
WO2020200916A1 (en) 2019-04-04 2020-10-08 Firmenich Sa Mogroside compounds and uses thereof
EP3982756A1 (en) * 2019-06-12 2022-04-20 CORN Products Development Inc. Compositions with sugar like characteristics
BR112021014587A2 (en) 2019-06-28 2022-01-04 Firmenich & Cie Fat mixtures, emulsions thereof and related uses
BR112022001006A2 (en) 2019-09-05 2022-04-12 Firmenich & Cie Flavanone derivatives and their use as sweetness enhancers
JP7763164B2 (en) 2019-09-30 2025-10-31 ジボダン エス エー Improvements in or relating to organic compounds
WO2021094268A1 (en) 2019-11-11 2021-05-20 Firmenich Sa Gingerol compounds and their use as flavor modifiers
EP4040986B1 (en) 2019-12-13 2025-12-24 Firmenich Incorporated Taste modifying compositions and uses thereof
US20230028760A1 (en) 2019-12-13 2023-01-26 Firmenich Incorporated Taste modifying compositions and uses thereof
KR20220114529A (en) 2019-12-18 2022-08-17 피르메니히 인코포레이티드 Taste modifying compositions and uses thereof
US20230000122A1 (en) 2019-12-18 2023-01-05 Firmenich Incorporated Taste modifying compositions and uses thereof
CN111170960B (en) * 2020-01-17 2022-04-15 东莞波顿香料有限公司 Meat flavor compound, preparation method thereof and flavor additive
EP4048086A1 (en) * 2020-03-05 2022-08-31 Firmenich SA 11-oxo-cucurbitanes and their use as flavor modifiers
CN115279206A (en) 2020-03-31 2022-11-01 弗门尼舍有限公司 Flavor composition
CN114096515B (en) 2020-04-17 2024-07-26 弗门尼舍有限公司 Amino acid derivatives and their use as flavor improvers
JP2023525620A (en) 2020-05-22 2023-06-19 フイルメニツヒ ソシエテ アノニム Compositions for reducing saltiness and uses thereof
US20240239771A1 (en) * 2020-05-29 2024-07-18 Taxis Pharmaceuticals, Inc. Bacterial efflux pump inhibitors
WO2021244953A1 (en) 2020-06-03 2021-12-09 Firmenich Sa Compositions for reducing off tastes and uses thereof
CN115701912A (en) 2020-06-24 2023-02-14 弗门尼舍有限公司 Sweetening compositions and uses thereof
EP4110475A1 (en) 2020-07-14 2023-01-04 Firmenich SA Reduction of undesirable taste notes in oral care products
KR20230041722A (en) * 2020-07-24 2023-03-24 피르메니히 인코포레이티드 Umami enhancement through binding of transmembrane regions
US20230338247A1 (en) 2020-09-22 2023-10-26 Firmenich Sa Wintergreen flavor compositions free of methyl salicylate
WO2022078974A1 (en) 2020-10-13 2022-04-21 Firmenich Sa Malonyl steviol glycosides and their comestible use
WO2022090218A1 (en) 2020-10-27 2022-05-05 Firmenich Sa Conjugated diynes and their use as flavor modifiers
EP4211469A1 (en) * 2020-11-24 2023-07-19 Firmenich Incorporated Kokumi taste enhancement and related screening methods
WO2022112432A1 (en) 2020-11-29 2022-06-02 Firmenich Sa Compositions that reduce peroxide off taste and uses thereof
US20230397627A1 (en) 2020-12-23 2023-12-14 Firmenich Sa Uses of fat blends and emulsions thereof
JPWO2022138890A1 (en) * 2020-12-25 2022-06-30
US20240292874A1 (en) 2021-01-08 2024-09-05 Symrise Ag Novel compositions for sour taste balancing
US20240058238A1 (en) 2021-01-13 2024-02-22 Firmenich Incorporated Compositions that enhance the cooling effect
WO2022155668A1 (en) 2021-01-15 2022-07-21 Firmenich Incorporated Sweetener compostions comprising siamenoside i and uses thereof
CN117098460A (en) 2021-01-15 2023-11-21 弗门尼舍公司 Sweetener composition comprising mogrosides and uses thereof
JP2024503101A (en) 2021-01-15 2024-01-24 フィルメニッヒ インコーポレイテッド Sweetener compositions containing mogrosides and their uses
EP4266904A1 (en) 2021-02-10 2023-11-01 Firmenich SA Fiber blends, sweetened fiber blends, and their comestible use
JP2024509300A (en) 2021-03-09 2024-02-29 フイルメニツヒ ソシエテ アノニム Hydroxy and methoxy substituted flavones and their uses
WO2022189156A1 (en) 2021-03-09 2022-09-15 Firmenich Sa Hydroxy- and methoxy-substituted flavonoids and their use
WO2022214275A1 (en) 2021-04-06 2022-10-13 Firmenich Sa Use of gingerdiol compounds to enhance flavor
CN117279520A (en) * 2021-04-26 2023-12-22 弗门尼舍公司 Amide compounds and their use as flavor modifiers
BR112023021909A2 (en) 2021-04-26 2023-12-19 Firmenich Incorporated AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS
JP2024517691A (en) 2021-04-26 2024-04-23 フィルメニッヒ インコーポレイテッド Amide compounds and their use as flavour modifiers - Patents.com
US20250275560A1 (en) 2021-05-11 2025-09-04 Firmenich Sa Process of making gingerol compounds and their use as flavor modifiers
WO2022248405A1 (en) 2021-05-24 2022-12-01 Firmenich Sa Flavored fiber blends and their comestible use
WO2022251628A1 (en) 2021-05-28 2022-12-01 Firmenich Incorporated Compositions that enhance the cooling effect
WO2022253681A1 (en) 2021-06-02 2022-12-08 Firmenich Sa Deacetylation process, compositions, and uses thereof
EP4329499A1 (en) 2021-06-23 2024-03-06 Firmenich SA Flavor-modifying compositions containing lactase
JP2024525438A (en) 2021-06-28 2024-07-12 フィルメニッヒ インコーポレイテッド Polycation salts of phenolic compounds and uses thereof
US20240237690A1 (en) 2021-06-29 2024-07-18 Firmenich Sa Licorice Compounds and Their Use as Flavor Modifiers
EP4333645B1 (en) 2021-06-29 2025-03-05 Firmenich Incorporated Mogroside compounds and their comestible use
WO2023046914A1 (en) 2021-09-27 2023-03-30 Firmenich Sa Flavor compositions containing iron compounds and their use
EP4384595A1 (en) 2021-09-27 2024-06-19 Firmenich Incorporated Use of vanillyl ethers to modify flavor of distilled spirits
CN116058486A (en) 2021-10-29 2023-05-05 味之素株式会社 Spicy taste enhancer composition and food
JP2024539838A (en) 2021-11-01 2024-10-31 フイルメニツヒ ソシエテ アノニム Compositions Comprising Nutrients and Taste Modifiers - Patent application
EP4404767A2 (en) * 2021-11-16 2024-07-31 Firmenich Incorporated Amide compounds and their use as flavor modifiers
US20250052739A1 (en) 2021-12-07 2025-02-13 Firmenich Incorporated Reduction of bitter taste of plant proteins and related assays and screening methods
EP4418872A1 (en) 2021-12-20 2024-08-28 Firmenich SA Encapsulated metal compounds and comestible uses thereof
WO2023117643A1 (en) 2021-12-23 2023-06-29 Firmenich Sa Antimicrobial composition having encapsulated colorant
CN114264766B (en) * 2021-12-31 2022-08-16 江苏艾兰得营养品有限公司 Evaluation method of sweet orange essence for VC soft sweets
EP4473004A1 (en) * 2022-02-11 2024-12-11 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof
US20250280861A1 (en) 2022-03-07 2025-09-11 Firmenich Incorporated Sweetener compositions
JP2025507547A (en) 2022-03-10 2025-03-21 フイルメニツヒ ソシエテ アノニム Sweetener Composition
WO2023172372A1 (en) * 2022-03-11 2023-09-14 Firmenich Incorporated Amide compounds and their use as flavor modifiers
CN118829632A (en) 2022-03-11 2024-10-22 弗门尼舍公司 Flavanone compounds and their use as flavor modifiers
WO2023180063A1 (en) 2022-03-25 2023-09-28 Firmenich Sa Fatty acid amides and their use as flavor modifiers
EP4460184A1 (en) 2022-03-28 2024-11-13 Firmenich SA Non-animal protein compositions and uses thereof
CA3254517A1 (en) 2022-04-06 2023-10-12 Firmenich Incorporated Taste modifying compositions and uses thereof
CN119183351A (en) 2022-04-11 2024-12-24 弗门尼舍有限公司 Sweetener composition
JP2025517320A (en) 2022-05-16 2025-06-05 フィルメニッヒ インコーポレイテッド Unsaturated fatty acids and their use for modifying taste - Patents.com
US20250275559A1 (en) 2022-05-16 2025-09-04 Firmenich Incorporated Saturated fatty acids and their use to modify taste
US20250344736A1 (en) 2022-06-03 2025-11-13 Firmenich Sa Fat reduction in non-animal protein compositions
CA3257371A1 (en) 2022-06-14 2023-12-21 Firmenich Sa Polyelectrolyte complexes of proteins and uses thereof
EP4507522A1 (en) 2022-06-24 2025-02-19 Firmenich SA Taste modifying compositions and uses thereof
US20250387310A1 (en) 2022-07-07 2025-12-25 Firmenich Incorporated Compositions that enhance the cooling effect
WO2024041974A1 (en) 2022-08-22 2024-02-29 Firmenich Sa Gel compositions and their use in seafood analogue products
WO2024089025A1 (en) 2022-10-26 2024-05-02 Firmenich Sa Extrusion methods and flavored products formed thereby
WO2024091457A1 (en) 2022-10-26 2024-05-02 Firmenich Incorporated Taste modifying compositions and uses thereof
EP4583718A1 (en) 2022-10-27 2025-07-16 Firmenich SA Flavonoid compositions and uses thereof
EP4580420A1 (en) 2022-11-01 2025-07-09 Firmenich SA Low-calorie composition for flavor modification
WO2024132554A1 (en) 2022-12-22 2024-06-27 Firmenich Sa Natural sweetener compositions and uses thereof
CN120417784A (en) 2022-12-22 2025-08-01 弗门尼舍有限公司 Natural sweetener composition containing alkyl lactate and use thereof
EP4601483A1 (en) 2022-12-23 2025-08-20 Firmenich Incorporated Beta-cyclodextrin and its use to modify flavor
CN120513026A (en) 2023-01-09 2025-08-19 弗门尼舍有限公司 Use of plant fibers for improving flavor of fermented products
EP4665157A1 (en) 2023-02-15 2025-12-24 Firmenich SA Thermoresponsive gel composition and uses thereof
EP4630413A1 (en) 2023-02-25 2025-10-15 Firmenich Incorporated Flavanone compounds and their use as flavor modifiers
EP4683521A1 (en) 2023-03-23 2026-01-28 Firmenich Incorporated Use of vanillyl ethers to modify flavor
EP4661689A1 (en) 2023-03-24 2025-12-17 Firmenich SA Microparticles containing algal proteins and uses thereof
WO2024200399A1 (en) 2023-03-28 2024-10-03 Firmenich Sa Taste-modifying compositions and uses thereof
CN120981169A (en) 2023-03-29 2025-11-18 弗门尼舍公司 Uses of fatty acids to modify flavor
WO2024208837A1 (en) 2023-04-04 2024-10-10 Firmenich Sa Polysaccharide compositions and their comestible use
AU2024262149A1 (en) * 2023-04-24 2025-12-11 Baylor College Of Medicine Inhibitors of jun n-terminal kinases (jnk1, jnk2, and/or jnk3) and mitogen-activated protein kinases (mapk8, mapk9, and/or mapk10) and methods of using same
WO2024227789A1 (en) 2023-05-03 2024-11-07 Firmenich Sa Encapsulated phenolic compounds and their comestible use
GB202307621D0 (en) 2023-05-22 2023-07-05 Givaudan Sa Improvements in or relating to organic compounds
EP4680039A1 (en) 2023-06-09 2026-01-21 DSM-Firmenich AG Compositions for reducing off notes and uses thereof
EP4480319A1 (en) 2023-06-22 2024-12-25 DSM-Firmenich AG Granola cluster
WO2025067974A1 (en) 2023-09-26 2025-04-03 Firmenich Sa Vegan cheese compositions and methods of making the same
WO2025073683A1 (en) 2023-10-04 2025-04-10 Firmenich Sa Flavanone compounds and their use as flavor modifiers
WO2025125286A1 (en) 2023-12-13 2025-06-19 Firmenich Sa Biopolymer compositions and their use in foamed compositions
WO2025132821A1 (en) 2023-12-19 2025-06-26 Firmenich Sa Comestible products having high fiber and low sugar
WO2025132803A1 (en) 2023-12-20 2025-06-26 Firmenich Sa 3-hydroxybenzoic acid and its use as a flavor modifier
WO2025191050A1 (en) 2024-03-15 2025-09-18 Firmenich Sa Lipid particles and their comestible use
WO2025202256A1 (en) 2024-03-28 2025-10-02 Firmenich Sa Cooling composition
WO2025221883A1 (en) 2024-04-17 2025-10-23 Firmenich Incorporated Taste modifying compositions and uses thereof
WO2025230968A1 (en) 2024-04-30 2025-11-06 Firmenich Incorporated Ketone compounds for enhancing alcohol perception

Family Cites Families (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US415052A (en) * 1889-11-12 And samuel j
US2987544A (en) 1961-06-06 Tranquilizers
BE418027A (en) 1935-10-22
GB502680A (en) 1936-10-10 1939-03-21 Du Pont Improvements in or relating to the isolation of boron fluoride
US2510945A (en) * 1945-04-24 1950-06-13 Us Agriculture Nu-cyclohexyl nicotinamide
US2519408A (en) * 1946-10-09 1950-08-22 Schering Corp Antispasmodics
NL93099C (en) * 1953-04-16
GB858333A (en) * 1956-10-05 1961-01-11 Unilever Ltd Flavouring substances and their preparation
US3098693A (en) 1960-05-27 1963-07-23 Little Inc A Treatment of protein and peptide materials to form amide linkages
US3492323A (en) * 1963-08-21 1970-01-27 Hoffmann La Roche N-(2-propynyloxy)-sulfanilamides
US3281330A (en) 1964-03-20 1966-10-25 Upjohn Co Microbiological process for the oxygenation of cycloalkanes
US3294544A (en) * 1964-11-06 1966-12-27 Richardson Merrell Inc Artificial sweetener-arabinogalactan composition and edible foodstuff utilizing same
GB1193289A (en) * 1965-07-14 1970-05-28 Science Union & Cie New Isoindolino-Sulphonylurea Derivatives and Process for Preparing them
NL129208C (en) * 1965-07-14
NL131479C (en) * 1966-04-20
US3398155A (en) * 1966-05-31 1968-08-20 Abbott Lab 2, 6-dichloro-isonicotinamide derivatives and a method for their preparation
DE1695428C3 (en) * 1967-06-08 1978-10-05 Merck Patent Gmbh, 6100 Darmstadt Derivatives of 5-mercaptopyridoxine and process for their preparation
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4136163A (en) * 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
US4021224A (en) * 1971-12-09 1977-05-03 Stauffer Chemical Company Herbicide compositions
US4034109A (en) * 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4177279A (en) * 1973-10-10 1979-12-04 John Wyeth & Brother Ltd. 1-[(3-Indolyl)-alkyl]-piperidyl ureas and hypotensive compositions
JPS5329211Y2 (en) 1973-10-15 1978-07-22
JPS5716973B2 (en) 1973-10-17 1982-04-08
GB1457671A (en) 1974-01-31 1976-12-08 Wilkinson Sword Ltd Flavour
GB1489359A (en) 1974-12-11 1977-10-19 Wilkinson Sword Ltd Alicyclic carboxamides having physiological cooling activity
US3944082A (en) 1974-12-20 1976-03-16 Harnischfeger Corporation Locking means for relatively movable boom sections of boom of mobile crane
JPS51106736A (en) * 1975-03-14 1976-09-21 Rikagaku Kenkyusho NOENGEI YOSATSUKINZAI
US3988510A (en) * 1975-05-29 1976-10-26 International Flavors & Fragrances Inc. 3-Furyl sulfides and foodstuff flavor compositions comprising same
GB1502680A (en) 1975-06-03 1978-03-01 Wilkinson Sword Ltd Compositions for application to or consumption by the human body and containing compounds having a physiological cooling effect
JPS5825980B2 (en) * 1976-02-12 1983-05-31 ヤマサ醤油株式会社 Cyclic nucleotide quantification method
US4049717A (en) * 1976-05-13 1977-09-20 American Cyanamid Company Novel 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamines and method of preparation thereof
US4332724A (en) * 1976-08-12 1982-06-01 American Cyanamid Co. Process for preparing 4,5,6,7-tetrahydro-7-oxobenzo[b]thiophenes and 1,2,3,4-tetrahydro-4-oxonaphthalenes
EP0005501B1 (en) 1978-05-20 1981-11-25 Bayer Ag Heteroaryloxy-acetamides, process for their preparation and their use as herbicides
US4535084A (en) 1979-10-15 1985-08-13 Pfizer Inc. Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity
US4535081A (en) * 1979-11-23 1985-08-13 Pfizer Inc. Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3164618D1 (en) 1980-12-22 1984-08-09 Schering Ag 3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them
US4517288A (en) * 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
DE3216843C2 (en) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridine derivatives, processes for their preparation and pharmaceuticals containing these compounds
FR2533210A1 (en) * 1982-09-17 1984-03-23 Lyon I Universite Claude SWEETENERS OF SYNTHESIS
GB8309855D0 (en) * 1983-04-12 1983-05-18 Tate & Lyle Plc Flavour modifiers
US4571345A (en) * 1983-06-13 1986-02-18 Cumberland Packing Corp. 1,1-Diaminoalkane derived sweeteners
US5476849A (en) * 1984-03-19 1995-12-19 The Rockefeller University Methods for glycosylation inhibition using amino-benzoic acids and derivatives
FR2573087B1 (en) * 1984-11-09 1987-07-10 Inst Francais Du Petrole METHOD OF SOFTENING OIL CUTTINGS CARRIED OUT IN THE ABSENCE OF AN ALKALINE COMPOUND
IL76842A0 (en) 1984-12-28 1986-02-28 Monsanto Co Novel n-acyl-n-isopropyl-glycine derivatives
JPS61200951A (en) * 1985-03-01 1986-09-05 Kyowa Hakko Kogyo Co Ltd Cyclopentanecarboxylic acid derivative
US5506337A (en) * 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPS61200951U (en) 1985-06-04 1986-12-16
JPS6181858A (en) 1985-08-09 1986-04-25 Honda Motor Co Ltd vehicle anti-lock braking system
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US4835181A (en) * 1987-02-18 1989-05-30 Eli Lilly And Company Anticonvulsant agents using cyano dimethylphenyl benzamides
JPH0784428B2 (en) * 1987-10-19 1995-09-13 鐘淵化学工業株式会社 Dipeptide derivative and sweetener containing the same
FR2624699B1 (en) * 1987-12-18 1990-04-13 Bernard Lyon I Universite Clau HETEROCYCLIC DERIVATIVES OF N-CARBAMOYL-, N-THIOCARBAMOYL- OR N-AMIDINO-GLYCINE OR BETA-ALANINE USEFUL AS SWEETENING AGENTS
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5176928A (en) * 1988-08-04 1993-01-05 The Nutrasweet Company Reduced calorie diary mix
JPH02108697A (en) * 1988-10-15 1990-04-20 Kanegafuchi Chem Ind Co Ltd Dipeptide derivative and peptide sweetener containing the same
US4910031A (en) 1988-12-19 1990-03-20 Frito-Lay, Inc. Topped savory snack foods
JPH02108697U (en) 1989-02-17 1990-08-29
US5001115A (en) 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
DE3916430A1 (en) 1989-05-20 1990-11-22 Bayer Ag METHOD FOR PRODUCING 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES
CA2020887A1 (en) 1989-07-28 1991-01-29 Michael Klaus Aromatic carboxylic amides
US5147463A (en) 1989-08-18 1992-09-15 Basf K&F Corporation Cyclic acetals
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5057601A (en) 1989-11-06 1991-10-15 Olin Corporation Process for producing a gel-free coagulated rubber with low ethylenic unsaturation
US5021249A (en) 1989-11-09 1991-06-04 Warner-Lambert Company Method of making a savory flavor granule and a free flowing savory flavor granule
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
HK1000547A1 (en) 1989-12-22 1998-04-03 Merck Serono Sa Endogenous gene expression modification with regulatory element by way of homologous recombination
US5180940A (en) 1990-02-09 1993-01-19 Asulab S.A. Radial field electrostatic micromotor produced using a photolithographic micromanufacturing technique and a process for producing said micromotor
JP2933975B2 (en) 1990-04-26 1999-08-16 長谷川香料株式会社 How to enhance the sweetness of food and drink
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
IL98764A0 (en) 1990-07-10 1992-07-15 Smithkline Beecham Corp Oxamides
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5508407A (en) * 1991-07-10 1996-04-16 Eli Lilly And Company Retroviral protease inhibitors
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
PT101031B (en) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc PROCESS FOR THE SUPPLY OF PROTEINS BY GENETIC THERAPY
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
FR2684670B1 (en) * 1991-12-05 1995-04-07 Commissariat Energie Atomique AMIDES WITH NITROGEN HETEROCYCLIC SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR SELECTIVELY EXTRACTING ACTINIDES (III) AND PARTICULARLY LANTHANIDES (III).
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5283722A (en) 1992-08-05 1994-02-01 Koenen Howard P Surgical-type glove and illuminator assembly
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US6664107B1 (en) * 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
US5426039A (en) * 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol
US5547966A (en) 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW406076B (en) * 1993-12-30 2000-09-21 Hoechst Ag Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
US5914349A (en) * 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
WO1995018617A1 (en) 1994-01-10 1995-07-13 Teva Pharmaceutical Industries Ltd. 1-aminoindan derivatives and compositions thereof
US5519134A (en) * 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) * 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5522175A (en) * 1994-06-01 1996-06-04 Biosource Technologies, Inc. Natural savory and umami flavoring materials from dehydrated mushroom
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) * 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
JPH08103243A (en) * 1994-10-06 1996-04-23 T Hasegawa Co Ltd Persistent aroma and flavor enhancer
DE69530067T2 (en) * 1994-10-07 2004-01-29 Firmenich & Cie AROMA COMPOSITION AND FLAVORING METHOD
US5801195A (en) 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
ZA96211B (en) 1995-01-12 1996-07-26 Teva Pharma Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
GB2299859B (en) 1995-04-10 1999-07-28 Otter Controls Ltd Thermally responsive steam sensor device
US6075055A (en) 1995-05-31 2000-06-13 Kumiai Chemical Industry Co., Ltd. Phenylalkane amide derivatives and agricultural or horticultural fungicides
EP0831854A4 (en) 1995-06-06 2001-01-24 Isis Pharmaceuticals Inc HIGH CHIRAL PURITY OLIGONUCLEOTIDES WITH PHOSPHOROTHIOATE LINKS
ATE483733T1 (en) 1995-06-14 2010-10-15 Univ California HIGH AFFINE HUMAN ANTIBODIES AGAINST TUMOR ANTIGENS
US5985662A (en) 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
CA2200209A1 (en) * 1995-07-26 1997-02-13 Eric Frerot Flavoured products and process for their preparation
EP0846112A1 (en) * 1995-08-25 1998-06-10 E.I. Du Pont De Nemours And Company Bicyclic herbicides
US6133317A (en) 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
AU1618697A (en) 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
JP2001510481A (en) * 1997-01-22 2001-07-31 イーライ・リリー・アンド・カンパニー Method for producing indane-like compound
BR9714328A (en) 1997-01-29 2000-03-21 Pfizer of interleukin-1 activity
WO2004096919A1 (en) * 1997-04-07 2004-11-11 Masahiro Suzuki Resin composition and adhesive film
AR013079A1 (en) 1997-05-06 2000-12-13 Smithkline Beecham Corp SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
MY119059A (en) 1997-08-11 2005-03-31 Cadbury Adams Usa Llc Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same
DE69828197T2 (en) * 1997-10-27 2005-12-08 Sumitomo Pharmaceuticals Co., Ltd. AMID DERIVATIVES FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDERS OF THE NETWORK
IL136250A0 (en) 1997-11-21 2001-05-20 Nps Pharma Inc Metabotropic glutamate receptor antagonist compounds
US6429207B1 (en) * 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
US6432454B1 (en) 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
ES2196753T3 (en) 1998-01-05 2003-12-16 Arla Foods Amba USE OF D-TAGATOSA COMOSINERGIZADOR AND INTENSIFIER OF TASTE.
DE19808261A1 (en) * 1998-02-27 1999-10-28 Bayer Ag Arylphenyl substituted cyclic ketoenols
DE19818732A1 (en) * 1998-04-27 1999-10-28 Bayer Ag New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides
WO1999059582A1 (en) * 1998-05-19 1999-11-25 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
EP1100811B1 (en) 1998-07-28 2007-07-04 The Regents Of The University Of California Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
US7402400B2 (en) * 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
CN1198836C (en) 1998-07-28 2005-04-27 加利福尼亚大学董事会 Nucleic acid encoding G-protein coupled receptors involved in sensory transduction
PE20000942A1 (en) 1998-07-31 2000-09-28 Lilly Co Eli DERIVATIVES OF AMIDE, CARBAMATE AND UREA
US6617351B1 (en) * 1998-07-31 2003-09-09 Eli Lilly And Company Amide, carbamate, and urea derivatives
JP2000169438A (en) 1998-10-02 2000-06-20 Kumiai Chem Ind Co Ltd Arylacetic acid amide derivatives and fungicides for agricultural and horticultural use
US6399731B2 (en) 1998-10-08 2002-06-04 The University Of Akron Chain transfer agents and its use in polymer synthesis
CN1213658C (en) * 1998-11-04 2005-08-10 明治制果株式会社 Pyridinecarboxamide derivative and pest control agent containing same as active ingredient
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AUPP891299A0 (en) 1999-02-26 1999-03-25 Fujisawa Pharmaceutical Co., Ltd. New 6-membered cyclic compounds
US6362165B1 (en) * 1999-03-30 2002-03-26 Pharmacor Inc. Hydroxyphenyl derivatives with HIV integrase inhibitory properties
JP2000344752A (en) * 1999-04-01 2000-12-12 Sumitomo Pharmaceut Co Ltd Eye drops
TW593241B (en) 1999-04-20 2004-06-21 Hoffmann La Roche Carbamic acid derivatives
US6368651B1 (en) * 1999-05-13 2002-04-09 The Nutrasweet Company Use of additives to modify the taste characteristics of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester
HUP0301764A3 (en) * 1999-07-20 2004-06-28 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
US6463445B1 (en) 1999-08-27 2002-10-08 Sony Electronics Inc. Multimedia information retrieval system and method including format conversion system and method
AU1607701A (en) 1999-11-15 2001-05-30 J. Manheimer, Inc. Flavor freshness enhancers
EP1254901A4 (en) * 2000-01-26 2003-03-05 Ono Pharmaceutical Co Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
JP3587361B2 (en) 2000-01-27 2004-11-10 キヤノン株式会社 Organic light emitting device
WO2002089593A1 (en) * 2000-02-03 2002-11-14 Kabushiki Kaisha Yakult Honsha Fermented foods and process for producing the same
JP3112457B2 (en) 2000-03-01 2000-11-27 曽田香料株式会社 Sweetness enhancer
TW201006846A (en) * 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
US6608176B2 (en) * 2000-03-31 2003-08-19 University Of Miami Taste receptor for umami (monosodium glutamate) taste
ATE336178T1 (en) 2000-04-06 2006-09-15 Quest Int FLAVORING FOODS WITH COMPOUNDS THAT CONTAIN A SULFUR ATOM BONDED TO TWO SPECIFIC ATOMS OR GROUPS
WO2001077292A2 (en) 2000-04-07 2001-10-18 Senomyx, Inc. Novel signal transduction molecules
JP2003530098A (en) * 2000-04-07 2003-10-14 セノミックス、インコーポレイテッド T2R taste receptor and gene encoding the same
DE10019145A1 (en) 2000-04-18 2001-10-25 Bayer Ag New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides
DE10021246A1 (en) 2000-04-25 2001-10-31 Schering Ag New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
CZ2003182A3 (en) 2000-06-21 2003-06-18 F. Hoffmann-La Roche Ag Benzothiazole derivatives
US7374878B2 (en) * 2000-06-22 2008-05-20 Senomyx, Inc. Receptor fingerprinting, sensory perception, and biosensors of chemical sensants
DE10030891A1 (en) * 2000-06-23 2002-01-03 Haarmann & Reimer Gmbh 3,4-Dihydroxybenzyl-substituted carbonic acid derivatives and their use as antioxidants in cosmetic and pharmaceutical preparations
US6399641B1 (en) 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
WO2002036622A2 (en) * 2000-10-30 2002-05-10 Senomyx, Inc. GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS
US7041457B2 (en) * 2000-10-30 2006-05-09 Senomyx, Inc. Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
US6365215B1 (en) 2000-11-09 2002-04-02 International Flavors & Fragrances Inc. Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
JP3744791B2 (en) 2000-12-01 2006-02-15 株式会社リコー Toner recycling apparatus and electrophotographic image forming apparatus having the same
TW201022287A (en) * 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
JP2002234898A (en) * 2001-02-08 2002-08-23 Ajinomoto Co Inc New n-alkylaspartyl dipeptide derivative and sweetener
JP2004523543A (en) 2001-02-15 2004-08-05 ニューロサーチ、アクティーゼルスカブ A method for treating Parkinson's disease by the combined action of a compound having neurotrophic activity and a compound increasing dopamine activity
DE10109856A1 (en) * 2001-03-01 2002-09-05 Bayer Ag Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus
US6617249B2 (en) 2001-03-05 2003-09-09 Agilent Technologies, Inc. Method for making thin film bulk acoustic resonators (FBARS) with different frequencies on a single substrate and apparatus embodying the method
US7368285B2 (en) * 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
US7309577B2 (en) * 2001-03-07 2007-12-18 Senomyx, Inc. Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
US6955887B2 (en) * 2001-03-30 2005-10-18 Senomyx, Inc. Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling
US7301009B2 (en) * 2001-06-26 2007-11-27 Senomyx, Inc. Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
DE10117823A1 (en) 2001-04-10 2002-10-17 Merck Patent Gmbh New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
EP1252825A1 (en) 2001-04-25 2002-10-30 Société des Produits Nestlé S.A. Flavouring compositions
US20030089885A1 (en) * 2001-04-25 2003-05-15 Senomyx, Inc. Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids
WO2002087306A2 (en) * 2001-05-01 2002-11-07 Senomyx, Inc. High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
DK2327985T3 (en) * 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
CN100489102C (en) * 2001-06-26 2009-05-20 塞诺米克斯公司 T1R hetero-oligomeric taste receptors and cell lines expressing same and their use in identifying taste compounds
EP1585954B1 (en) * 2001-07-03 2014-03-26 The Regents of The University of California Mammalian sweet and amino acid heterodimeric taste receptors
CN1309736C (en) * 2001-07-06 2007-04-11 塞诺米克斯公司 Expression of functional human olfactory cyclic nucleotide gated (CNG)channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
JP4551656B2 (en) * 2001-07-10 2010-09-29 セノミックス インコーポレイテッド Use of specific T2R taste receptors to identify compounds that block bitterness
CZ2004168A3 (en) 2001-08-06 2004-05-12 Pharmaciaáitaliaás@P@A Aminoisoxazole derivatives exhibiting activity as kinase inhibitors, process of their preparation and pharmaceutical composition in which the derivatives are comprised
EP1291342A1 (en) * 2001-09-06 2003-03-12 Societe Des Produits Nestle S.A. Pyridinium-betain compounds as taste enhancer
CN1556788A (en) * 2001-09-21 2004-12-22 muscarinic receptor agonists
JP4840837B2 (en) * 2001-09-28 2011-12-21 日本たばこ産業株式会社 Novel peptide having umami taste and seasoning containing umami ingredient
JPWO2003030937A1 (en) 2001-10-05 2005-01-20 小野薬品工業株式会社 A therapeutic agent for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
ES2256560T3 (en) 2001-10-12 2006-07-16 Bayer Pharmaceuticals Corporation HETEROCICLOS OF 5 MEMBERS CONTAINING NITROGEN SUBSTITUTED WITH FELINE FOR THE TREATMENT OF OBESITY.
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
CN1205175C (en) * 2001-11-02 2005-06-08 中国人民解放军军事医学科学院毒物药物研究所 Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science
US7329426B2 (en) 2001-11-13 2008-02-12 Applied Food Biotechnology, Inc. Treatment of vegetable oils or animal fats with sulfur or nitrogen donor compounds for animal food flavorings
EP1312268A1 (en) * 2001-11-19 2003-05-21 Société des Produits Nestlé S.A. Flavouring compositions
US7208290B2 (en) * 2001-12-14 2007-04-24 Senomyx, Inc. Methods of co-expressing umami taste receptors and chimeric Gα15 variants
US7344845B2 (en) * 2001-12-21 2008-03-18 Senomyx, Inc. Olfactory receptor for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor
DE50206069D1 (en) * 2001-12-27 2006-05-11 Symrise Gmbh & Co Kg Use of ferulic acid amides as flavoring agents
US7057040B2 (en) 2002-02-07 2006-06-06 Council Of Scientific And Industrial Research Substituted aryl alkenoic acid heterocyclic amides
US6818772B2 (en) * 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
AU2003235125A1 (en) 2002-04-26 2003-11-10 Ishihara Sangyo Kaisha, Ltd. Pyridine compounds or salts thereof and herbicides containing the same
WO2003103647A1 (en) * 2002-06-05 2003-12-18 株式会社医薬分子設計研究所 Inhibitors against the activation of ap-1 and nfat
US20040006135A1 (en) 2002-06-19 2004-01-08 Pfizer Inc. Combination treatment for depression and anxiety
AU2003261280B2 (en) 2002-07-29 2009-02-05 Senomyx, Inc. Identification of a novel bitter taste receptor, T2R76
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
US7635709B2 (en) * 2002-09-26 2009-12-22 The United States Of America As Represented By The Department Of Veterans Affairs Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction
PT1603928E (en) 2003-03-10 2007-08-31 Nestec Sa Pyridinium-betain compounds and their use
BRPI0408284B8 (en) 2003-03-12 2021-05-25 Kudos Pharm Ltd phthalazinone derivatives, their use and pharmaceutical composition comprising them
CN1784411A (en) 2003-04-08 2006-06-07 弗莱克特瑞尔公司 Fragrance compositions comprising benzo[4,5]thieno[3,2-b]pyran-2-one
EP1618090A1 (en) 2003-04-11 2006-01-25 Novo Nordisk A/S 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
US20060094699A1 (en) * 2003-04-11 2006-05-04 Kampen Gita Camilla T Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
CN1826324B (en) 2003-05-22 2011-12-07 雅培制药有限公司 Indazole, Benzisoxazole, and Benzisothiazole Kinase Inhibitors
CN103275058B (en) 2003-08-06 2016-02-24 西诺米克斯公司 Seasonings, taste modulators, tastant, taste enhancer, tasty agents or sweeting agent and/or toughener and uses thereof
US20060045953A1 (en) * 2004-08-06 2006-03-02 Catherine Tachdjian Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
US7191089B2 (en) 2004-12-01 2007-03-13 Freescale Semiconductor, Inc. System and method for fall detection
US7711312B2 (en) 2005-02-03 2010-05-04 Educational Testing Service Method and system for detecting off-topic essays without topic-specific training
KR101340859B1 (en) 2005-02-04 2013-12-13 세노믹스, 인코포레이티드 Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
US20060257543A1 (en) * 2005-02-04 2006-11-16 Catherine Tachdjian Molecules comprising linked organic moieties as flavor modifiers for comestible compositions
TW200715993A (en) 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
EP3235811B1 (en) 2006-04-21 2018-07-25 Senomyx, Inc. Process of preparing oxalamides

Also Published As

Publication number Publication date
US9459250B2 (en) 2016-10-04
US20200225217A1 (en) 2020-07-16
EP1659881A2 (en) 2006-05-31
US7476399B2 (en) 2009-01-13
PH12015501666A1 (en) 2018-06-11
ZA200601904B (en) 2007-10-31
JP2007517493A (en) 2007-07-05
WO2005015158A9 (en) 2005-05-19
NZ627505A (en) 2016-01-29
MY174572A (en) 2020-04-27
RU2006106919A (en) 2007-09-20
US20180364220A1 (en) 2018-12-20
JP5036310B2 (en) 2012-09-26
CA2535036A1 (en) 2005-05-12
PH12015501664A1 (en) 2019-11-25
US9091686B2 (en) 2015-07-28
AU2011201468A1 (en) 2011-04-21
CL2016003325A1 (en) 2017-06-09
AU2011201468C1 (en) 2015-02-19
NZ619746A (en) 2014-05-30
US20130030059A1 (en) 2013-01-31
BRPI0413347A (en) 2006-10-10
PH12015501667A1 (en) 2018-06-11
CN103275058B (en) 2016-02-24
CA2900181A1 (en) 2005-05-12
US20120201763A1 (en) 2012-08-09
US20150093339A1 (en) 2015-04-02
EP1659881A4 (en) 2013-05-15
PH12015501665A1 (en) 2021-09-01
US20090111834A1 (en) 2009-04-30
AU2011201468C9 (en) 2016-04-21
PH12015501667B1 (en) 2020-09-25
NZ545747A (en) 2010-06-25
AU2004285410A1 (en) 2005-05-12
AR046078A1 (en) 2005-11-23
US10352929B2 (en) 2019-07-16
WO2005041684A2 (en) 2005-05-12
US20220326230A1 (en) 2022-10-13
IL207954A0 (en) 2010-12-30
US20150064112A1 (en) 2015-03-05
CN103275058A (en) 2013-09-04
PH12015501663B1 (en) 2019-10-16
AU2004285410B2 (en) 2011-04-14
US8895050B2 (en) 2014-11-25
IL173551A0 (en) 2006-07-05
CA2535036C (en) 2015-11-24
MXPA06001510A (en) 2006-09-04
PH12015501662B1 (en) 2018-04-30
EP3431464A3 (en) 2019-07-31
SG145745A1 (en) 2008-09-29
RU2419602C2 (en) 2011-05-27
US20200049699A1 (en) 2020-02-13
IL173552A (en) 2012-10-31
NZ545746A (en) 2012-03-30
PH12015501663A1 (en) 2018-06-25
BRPI0413324A (en) 2006-10-10
EP1659881B1 (en) 2019-04-03
US20180003702A1 (en) 2018-01-04
PH12016501312A1 (en) 2017-06-05
US11268952B2 (en) 2022-03-08
ES2733577T3 (en) 2019-12-02
AU2004263871A1 (en) 2005-02-17
WO2005015158A3 (en) 2007-01-04
JP2007512227A (en) 2007-05-17
EP1660859A4 (en) 2012-10-10
IL173551A (en) 2013-11-28
US7888470B2 (en) 2011-02-15
EP3431464A2 (en) 2019-01-23
US20080085994A1 (en) 2008-04-10
WO2005015158A2 (en) 2005-02-17
US8404455B2 (en) 2013-03-26
JP2008013570A (en) 2008-01-24
US10060909B2 (en) 2018-08-28
US20130336892A1 (en) 2013-12-19
CA2900181C (en) 2019-01-29
US8124121B2 (en) 2012-02-28
NZ580418A (en) 2012-03-30
CL2004002015A1 (en) 2005-05-13
JP2007330268A (en) 2007-12-27
RU2010112728A (en) 2011-10-10
JP5036446B2 (en) 2012-09-26
SG153714A1 (en) 2009-07-29
RU2006106920A (en) 2007-09-20
NZ597500A (en) 2014-08-29
PH12016501311A1 (en) 2017-06-05
AU2011201468B2 (en) 2014-02-20
US20070104709A1 (en) 2007-05-10
EP1660859A2 (en) 2006-05-31
US10557845B2 (en) 2020-02-11
PH12015501662A1 (en) 2018-04-30
PH12016501311B1 (en) 2017-06-05
US20110294981A1 (en) 2011-12-01
AU2004263871B2 (en) 2011-07-14
PH12015501666B1 (en) 2018-06-11
WO2005041684A3 (en) 2009-04-09
US8735081B2 (en) 2014-05-27
US20050084506A1 (en) 2005-04-21
CA2535045A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
IL173552A0 (en) T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds
AU154526S (en) Spout
AU155036S (en) Spout
IL169498A0 (en) Pourer
GB0226227D0 (en) Receptors
AU2003297833A8 (en) Canine rankl and methods for preparing and using the same
IL173337A0 (en) Receptor
GB0322416D0 (en) Saddle
HK1087467A (en) T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
PL1502500T3 (en) Pivotable drinking through
GB0223399D0 (en) Receptors
AU302414S (en) Spout
AU2003287607A8 (en) Multi-fluid applicator
GB0321998D0 (en) Receptor
GB0304065D0 (en) Receptors
GB0316354D0 (en) Receptors
GB0302604D0 (en) Receptors
GB0308309D0 (en) Receptors
GB0304090D0 (en) Receptors
GB0304064D0 (en) Receptors
GB0314113D0 (en) Receptors
GB0303263D0 (en) Line drag reduction device
GB0316465D0 (en) Adjustable container
AU152412S (en) Spout
AU153932S (en) Spout

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed